TNFRSF10B and lung carcinoma: What's more, the newly identified miR-1246/DR5 axis sheds light on the molecular mechanism of lung cancer radioresistance, indicating that it is a potential strategies to treat radioresistant lung cancer by inhibiting miR-1246 or activating the DR5.